Study #2021-0521
Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients with Colorectal Liver Metastases
MD Anderson Study Status
Enrolling
Treatment Agent
Yttrium-90 (Y-90) resin microspheres
Description
A prospective, interventional study evaluating the safety of Y-90 TARE for tumor control of the right side and induction of left liver hypertrophy as part of a planned single-stage or two-stage hepatectomy for patients with CLM and insufficient FLR at the time of presentation.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Metastases
Study phase:
Phase I
Physician name:
Ching-Wei Tzeng
Department:
Surgical Oncology
For general questions about clinical trials:
1-888-714-4981
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.